Erica Herrera has persevered through problems that would sink many people, getting a degree from UWM and building a successful business. Now, she’s enrolled in the Executive MBA program and looking for more.
UWM is building future-focused strategic partnerships with both local and international companies and engaging with them in new ways, Chancellor Mark Mone told a committee of the UW System Board of Regents meeting at UWM on June 3.
Winners of the New Ventures Business Plan Competition hosted by UWM’s Lubar School of Business include a tool handle to aid female do-it-yourselfers, a 360-degree-view digital product and a company that helps women find their path in life.
Health professionals treating hard-to-heal wounds have long been saddled with inadequate tools. Now, two UWM researchers have invented a better way.
Five UWM startup companies have been awarded the first round of funding from the UWM Research Foundation’s new bridge grant program, which leverages a $200,000 matching grant from the Wisconsin Economic Development Corporation that was announced last year.
For John Harry, a graduate student in history at UWM, the story of Peoples Brewery in Oshkosh, Wisconsin’s first and only Black-owned brewery, is a way to tell the history of how Black entrepreneurs tried to make a place for themselves in society.
The pandemic has prompted an explosion of remote work. But for those with disabilities, working from home can be fraught with challenges. UWM researchers are helping create a tool to identify those problems.
The U.S. Department of Energy recently awarded funding to a startup launched by two UWM professors for a collaboration with the Argonne National Laboratory in suburban Chicago on research that will help their company commercialize the material.
The grants totaling $200,000 back projects focused on 3D concrete printing, removal of PFAS contamination from the environment, better aquaculture filtration, a novel biological pesticide for crops and a smartphone app for wound healing.
The newly licensed compounds, developed by the laboratory of James Cook, act on a particular neurotransmitter receptor in the brain, which has shown promise for treatment of epilepsy and other convulsant disorders.